Human medicines
Marcoumar
In a letter dated July 13, 2011, the marketing authorization holder informed its supplied customers that, in addition to the tablets, glass splinters…
Irinoliquid
In a letter dated July 7, 2011, the marketing authorization holder informed its customers that stability tests had revealed that the active ingredient…
Xylanaest 1 % with epinephrine
The marketing authorization holder informed its supplied customers in a letter dated July 5, 2011, that due to a calculation error an incorrect…
Rocaltrol
The medicinal product imported from Switzerland is being recalled as a precautionary measure, as stability tests have shown that the specified active…
Wobenzyme
The marketing authorization holder informed its supplied customers in a letter dated June 28, 2011, that due to a minor deviation (falling below the…
Phlogenzyme
The marketing authorization holder informed its supplied customers in a letter dated June 28, 2011, that due to a minor deviation (falling below the…
Calcium "Fresenius"-Ampullen
The marketing authorization holder informed its supplied customers by letter dated 06.06.2011 that a precautionary recall is being carried out due to…
Pridax
The marketing authorization holder informed its supplied customers in a letter dated May 26, 2011, that the degradation product prostaglandin A1…
Braunoderm
The marketing authorization holder informed its supplied customers in a letter dated May 20, 2011, that the content of available iodine in the three…
Prezista
The marketing authorization holder informed its supplied customers in a letter dated May 11, 2011, that due to reports of an unpleasant, moldy odor,…
